VYNE Therapeutics (VYNE) Current Leases (2019 - 2025)
VYNE Therapeutics (VYNE) posted Current Leases of $25000.0 for Q2 2025, down 60.32% on a QoQ basis from $63000.0 in Q1 2025, and down 79.17% year-over-year from $120000.0 in Q2 2024.
VYNE Therapeutics (VYNE) Current Leases (2019 - 2025) Analysis & Trends
VYNE Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $25000.0 for Q2 2025.
- Quarterly Current Leases fell 79.17% year-over-year to $25000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $25000.0 (down 79.17% YoY) and the FY2024 annual result came in at $99000.0, down 13.91% from the prior year.
- Current Leases was $25000.0 for Q2 2025 at VYNE Therapeutics, down from $63000.0 in the prior quarter.
- Across five years, Current Leases topped out at $647000.0 in Q1 2021 and bottomed at $25000.0 in Q2 2025.
- A 5-year average of $192307.7 and a median of $117000.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases tumbled 92.86% — and 2024, when it dropped 13.91%.
- VYNE Therapeutics' Current Leases stood at $349000.0 in 2021, then sank by 91.12% to $31000.0 in 2022, then surged by 270.97% to $115000.0 in 2023, then decreased by 13.91% to $99000.0 in 2024, then slumped by 74.75% to $25000.0 in 2025.
- Business Quant data shows VYNE's Current Leases at $25000.0 in Q2 2025, $63000.0 in Q1 2025, and $99000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.61 Mn |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 63,000.00 |
| Dec 31, 2024 | 99,000.00 |
| Sep 30, 2024 | 123,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 117,000.00 |
| Dec 31, 2023 | 115,000.00 |
| Jun 30, 2022 | 31,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 349,000.00 |
| Sep 30, 2021 | 277,000.00 |
| Jun 30, 2021 | 434,000.00 |
| Mar 31, 2021 | 647,000.00 |
| Dec 31, 2020 | 757,000.00 |
| Sep 30, 2020 | 1.10 Mn |
| Jun 30, 2020 | 1.25 Mn |
| Mar 31, 2020 | 1.01 Mn |
| Dec 31, 2019 | 1.09 Mn |